Related Experiment Video

Updated: Jun 26, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K

Automating Chart Review Utilizing an Artificial Intelligence-Enabled System for Assessing Transthyretin Amyloid

Trejeeve Martyn1, Mazen Hanna2, Steven E Nissen3

  • 1Cleveland Clinic, Heart Vascular & Thoracic Institute, Department of Cardiovascular Medicine, Cleveland, Ohio; George and Linda Kaufman Center for Heart Failure and Recovery, Cleveland Clinic, Cleveland, Ohio; C5 Research, Cleveland Clinic, Cleveland, Ohio.

Journal of Cardiac Failure
|March 5, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Artificial IntelligenceCardiac AmyloidosisClinical TrialsLarge-Language Models

More Related Videos

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.9K

Related Experiment Videos

Last Updated: Jun 26, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K
Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Articles linked to this work by shared authors, journal, and citation graph.

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

Lancet (London, England)·2026

Pacemaker Implantation in Patients With Pre-Existing Bundle Branch Block Undergoing Balloon-Expandable Transcatheter Aortic Valve Replacement.

Structural heart : the journal of the Heart Team·2026

Global and Domain-Specific Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation.

JAMA network open·2026

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

JAMA·2026

Socioeconomic status and epilepsy surgery in the United States: Timing and outcomes.

Epilepsia·2026

Tissue Screening and Diagnosis of Transthyretin Amyloid Cardiomyopathy.

Reviews in cardiovascular medicine·2026

From Rescue to Interception: The PREVENT 2-LATE Framework for Advanced Heart Failure.

Journal of cardiac failure·2026

Development and Independent Validation of a Machine Learning-Based Non-Invasive Venous Waveform Analysis for Heart Failure (NIVAHF) Device to Estimate Pulmonary Capillary Wedge Pressure.

Journal of cardiac failure·2026

Inpatient Initiation of Target-Dose ACE Inhibitors and Lower Risk of Death or Kidney Failure in Veterans With HFrEF: Results From the National DCVA-HF Registry.

Journal of cardiac failure·2026

Machine Learning Predicts Functional Decline and Risk Phenotypes in Older Patients With Heart Failure.

Journal of cardiac failure·2026

The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Journal of cardiac failure·2026

Beta-Blocker Discontinuation in Heart Failure with Preserved or Improved Ejection Fraction: A Systematic Review.

Journal of cardiac failure·2026

Artificial intelligence in physical and rehabilitation medicine: first update of the living systematic mapping review up to May 31st, 2025.

European journal of physical and rehabilitation medicine·2026

Generative Artificial Intelligence in Peripheral Blood Morphology: Synthetic Image Creation and Digital Stain Normalization.

International journal of laboratory hematology·2026

Insights into the use of artificial intelligence in the drug discovery and delivery of nanosystems for the treatment of infectious diseases and neoplasms.

Nanomedicine (London, England)·2026

Aggregation-Enhanced Photocleavage for Time-Resolved Multicolor Fluorescence Encryption and Quaternary Optical Storage.

Angewandte Chemie (International ed. in English)·2026

Artificial Intelligence Integration With Nanotechnology for Cancer Therapy.

MedComm·2026

A Review of the Role of Artificial Intelligence in Patients on Extracorporeal Membrane Oxygenation: A Scoping Review Study.

Health science reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us